drugset
Drugs / Red Blood Cell
last change Jul 2026 re-read 3 minutes ago

Red Blood Cell

also known as Red blood cell (RBC)
Developed for
sickle cell disease
Investigated by
National Heart, Lung, and Blood Institute (NHLBI) · University of Pittsburgh

Trials 1

today NCT04084080 · Ph 3
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04084080 Feb 2020 → Jul 2026 overdue sickle cell disease University of Pittsburgh Active not recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Red Blood Cell ClinicalTrials.gov intervention name — accepted as the source's own label NCT04084080 ↗
Known as Red blood cell (RBC) “Red blood cell (RBC)” NCT04084080 ↗